Evogene Ltd (NASDAQ:EVGN)’s share price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.37 and last traded at $2.39, with a volume of 2732 shares. The stock had previously closed at $2.40.

Separately, ValuEngine raised Evogene from a “hold” rating to a “buy” rating in a report on Wednesday, November 7th.

A hedge fund recently raised its stake in Evogene stock. ARK Investment Management LLC increased its stake in shares of Evogene Ltd (NASDAQ:EVGN) by 169.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 167,347 shares of the biotechnology company’s stock after buying an additional 105,188 shares during the quarter. ARK Investment Management LLC owned about 0.65% of Evogene worth $479,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 35.29% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/12/08/evogene-evgn-reaches-new-1-year-low-at-2-37.html.

Evogene Company Profile (NASDAQ:EVGN)

Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States, Germany, and internationally. It operates through three segments: Evogene, Evofuel, and Biomica. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

Recommended Story: How Investors Use a Balance Sheet

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.